Cargando…
Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease
Since the outbreak of the 2019 novel coronavirus disease (COVID-19), the medical research community is vigorously seeking a treatment to control the infection and save the lives of severely infected patients. The main potential candidates for the control of viruses are virally targeted agents. In th...
Autores principales: | Qiao, Zhen, Zhang, Hongtao, Ji, Hai-Feng, Chen, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357730/ https://www.ncbi.nlm.nih.gov/pubmed/32661494 http://dx.doi.org/10.3390/computation8020053 |
Ejemplares similares
-
A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease
por: Hall, Donald C., et al.
Publicado: (2020) -
Inhibition of SARS-CoV 3CL protease by flavonoids
por: Jo, Seri, et al.
Publicado: (2019) -
A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main proteases
por: Pushkaran, Anju Choorakottayil, et al.
Publicado: (2021) -
Testing Affordable Strategies for the Computational
Study of Reactivity in Cysteine Proteases: The Case of SARS-CoV-2
3CL Protease Inhibition
por: Ramos-Guzmán, Carlos A., et al.
Publicado: (2022) -
Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein
por: Lemmin, Thomas, et al.
Publicado: (2020)